Clinical Trial Update: Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD [Phase 2]

View source ↗

Summary

Phase 2 randomized, single-masked long-term safety and tolerability study evaluating VEGF Trap-Eye (aflibercept) in age-related macular degeneration; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• VEGF Trap-Eye (aflibercept)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2013-06-12